Relmada Therapeutics, Inc. (TRADEGATE:4E2) People

Relmada Therapeutics, Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Charles J. Casamento
Other companies: GT Biopharma, Inc. (Director · Since at least May 1, 2023); Eton Pharmaceuticals, Inc. (Director · Since at least Nov 9, 2018); PaxMedica, Inc. (Director · Oct 1, 2022 – Mar 12, 2024 · Past); GridAI Technologies Corp. (Director · Mar 3, 2017 – Jan 2, 2024 · Past); International Stem Cell Corporation (Director · Mar 31, 2016 – Jun 21, 2018 · Past)
Chairman of the Board · Since at least Oct 20, 2017
Douglas Beck
Other companies: SHF Holdings, Inc. (PAO SVP of Finance Controller · Since at least Sep 24, 2025); ShiftPixy Inc (Chief Financial Officer · Jan 15, 2023 – Jan 15, 2023 · Past); Beyond Air, Inc. (Chief Financial Officer · Nov 1, 2018 – Jun 16, 2021 · Past); iBio, Inc. (Chief Financial Officer · May 3, 2011 – May 3, 2011 · Past); Lev Pharmaceuticals Inc (Chief Financial Officer · Jun 7, 2006 – Jun 7, 2006 · Past)
Chief Financial Officer · Jan 6, 2015 – Feb 23, 2015 · Past
Eric Thomas Schmidt
Other companies: Revolution Medicines, Inc. (Director · Jun 17, 2020 – Jun 8, 2023 · Past); Allogene Therapeutics, Inc. (Chief Financial Officer · Oct 10, 2018 – Mar 22, 2023 · Past)
Director · Dec 19, 2019 – May 25, 2023 · Past
Maged Shenouda
Other companies: GridAI Technologies Corp. (CHIEF FINANCIAL OFFICER, Director · Oct 11, 2016 – Dec 28, 2018 · Past); Protea Biosciences Group (Director · Apr 17, 2015 – Dec 18, 2015 · Past)
Chief Financial Officer · Since at least Nov 12, 2015
Chuck Ence
Other companies: Newage Inc (Chief Financial Officer · Sep 15, 2016 – Sep 15, 2016 · Past)
Chief Accounting and Compliance Officer · Since at least Jul 29, 2019
Lisa Nolan
Other companies: Opus Genetics, Inc. (Chief Business Officer · Jul 6, 2016 – Feb 28, 2019 · Past)
Chief Business Officer · Dec 14, 2015 – Dec 14, 2015 · Past
Sandesh Seth
Other companies: Actinium Pharmaceuticals, Inc. (Delaware) (Chief Executive Officer and Chairman of the Board · Since at least Dec 28, 2012)
Director · Jan 6, 2015 – Dec 15, 2015 · Past
Sergio Traversa
Other companies: Actinium Pharmaceuticals, Inc. (Delaware) (Director · Dec 28, 2012 – Mar 14, 2017 · Past)
Chief Executive Officer · Since at least Jan 6, 2015
Thomas Wessel
Other companies: Decoy Therapeutics Inc. (Chief Medical Officer · Jan 17, 2018 – Jan 17, 2018 · Past)
EVP, Head of R&D · Mar 9, 2020 – Mar 9, 2020 · Past
Bipin DalmiaChief Business Officer · Since Jul 28, 2026
Cedric O'GormanChief Medical Officer · Jan 6, 2023 – May 23, 2023 · Past
Fabiana FedeliDirector · Since at least Jan 12, 2023
John GlasspoolDirector · Since at least Dec 17, 2021
Jørn Skibsted JakobsenChief Development Officer, Urology & Uro-Oncology · Since Nov 16, 2026
Nabil YazgiDirector · Jan 6, 2015 – Jan 6, 2015 · Past
Ottavio V VitoloCMO · Apr 2, 2018 – Dec 19, 2019 · Past
Paul KellyChief Operating Officer · Since at least Nov 12, 2015
Shreeram AgharkarDirector · Dec 16, 2015 – Dec 31, 2015 · Past
Yair LotanChair of Relmada’s Clinical Advisory Board · Jul 15, 2025 – Nov 4, 2026 · Past